Clinical Trial Detail

NCT ID NCT00908167
Title Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Clofarabine + Cytarabine + Sorafenib

Age Groups: adult child

No variant requirements are available.